These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30986516)

  • 1. Significance of liquid biopsy in glioblastoma - A review.
    Klekner Á; Szivos L; Virga J; Árkosy P; Bognár L; Birkó Z; Nagy B
    J Biotechnol; 2019 Jun; 298():82-87. PubMed ID: 30986516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges.
    Seyhan AA
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Functionalized Superlattice Nanosensor Enables Glioblastoma Diagnosis Using Liquid Biopsy.
    Premachandran S; Haldavnekar R; Ganesh S; Das S; Venkatakrishnan K; Tan B
    ACS Nano; 2023 Oct; 17(20):19832-19852. PubMed ID: 37824714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application.
    Szilágyi M; Pös O; Márton É; Buglyó G; Soltész B; Keserű J; Penyige A; Szemes T; Nagy B
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging circulating biomarkers in glioblastoma: promises and challenges.
    Touat M; Duran-Peña A; Alentorn A; Lacroix L; Massard C; Idbaih A
    Expert Rev Mol Diagn; 2015; 15(10):1311-23. PubMed ID: 26394701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid biopsy: A new avenue in pathology.
    Ghosh RK; Pandey T; Dey P
    Cytopathology; 2019 Mar; 30(2):138-143. PubMed ID: 30485558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring.
    Hallal S; Ebrahimkhani S; Shivalingam B; Graeber MB; Kaufman KL; Buckland ME
    Brain Tumor Pathol; 2019 Apr; 36(2):29-39. PubMed ID: 30859343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Significance of Extracellular Vesicles in Plasma from Glioblastoma Patients.
    Osti D; Del Bene M; Rappa G; Santos M; Matafora V; Richichi C; Faletti S; Beznoussenko GV; Mironov A; Bachi A; Fornasari L; Bongetta D; Gaetani P; DiMeco F; Lorico A; Pelicci G
    Clin Cancer Res; 2019 Jan; 25(1):266-276. PubMed ID: 30287549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Plasma Extracellular Vesicle Isolation and Proteomic Characterization for the Optimization of Liquid Biopsy in Multiple Myeloma.
    Reale A; Khong T; Xu R; Chen M; Mithraprabhu S; Bingham N; Spencer A; Greening DW
    Methods Mol Biol; 2021; 2261():151-191. PubMed ID: 33420989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of tumor-derived exosomes for noninvasive cancer monitoring: an update.
    Whiteside TL
    Expert Rev Mol Diagn; 2018 Dec; 18(12):1029-1040. PubMed ID: 30406709
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel Molecular Markers in Glioblastoma-Benefits of Liquid Biopsy.
    Birkó Z; Nagy B; Klekner Á; Virga J
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053907
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular and Circulating Biomarkers of Brain Tumors.
    Jelski W; Mroczko B
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34210107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth.
    Setti M; Osti D; Richichi C; Ortensi B; Del Bene M; Fornasari L; Beznoussenko G; Mironov A; Rappa G; Cuomo A; Faretta M; Bonaldi T; Lorico A; Pelicci G
    Oncotarget; 2015 Oct; 6(31):31413-27. PubMed ID: 26429879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsy for liver diseases.
    Mann J; Reeves HL; Feldstein AE
    Gut; 2018 Dec; 67(12):2204-2212. PubMed ID: 30177542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small extracellular vesicles as tumor biomarkers for glioblastoma.
    Mahmoudi K; Ezrin A; Hadjipanayis C
    Mol Aspects Med; 2015 Nov; 45():97-102. PubMed ID: 26118341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating extracellular vesicles as biomarker for diagnosis, prognosis, and monitoring in glioblastoma patients.
    Ricklefs FL; Wollmann K; Salviano-Silva A; Drexler R; Maire CL; Kaul MG; Reimer R; Schüller U; Heinemann S; Kolbe K; Mummert T; Glatzel M; Peine S; Gempt J; Westphal M; Dührsen L; Lamszus K
    Neuro Oncol; 2024 Jul; 26(7):1280-1291. PubMed ID: 38567448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicles: The key for precision medicine in glioblastoma.
    Del Bene M; Osti D; Faletti S; Beznoussenko GV; DiMeco F; Pelicci G
    Neuro Oncol; 2022 Feb; 24(2):184-196. PubMed ID: 34581817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies, considerations, and recent advancements in the development of liquid biopsy for glioblastoma: a step towards individualized medicine in glioblastoma.
    Bauman MMJ; Bouchal SM; Monie DD; Aibaidula A; Singh R; Parney IF
    Neurosurg Focus; 2022 Dec; 53(6):E14. PubMed ID: 36455271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating biomarkers in patients with glioblastoma.
    Müller Bark J; Kulasinghe A; Chua B; Day BW; Punyadeera C
    Br J Cancer; 2020 Feb; 122(3):295-305. PubMed ID: 31666668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunities and Challenges of Liquid Biopsy in Thyroid Cancer.
    Romano C; Martorana F; Pennisi MS; Stella S; Massimino M; Tirrò E; Vitale SR; Di Gregorio S; Puma A; Tomarchio C; Manzella L
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.